Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Atossa Therapeutics, Inc. (($ATOS)) has held its Q4 earnings call. Read on for the main highlights of the call. Atossa Therapeutics’ recent ...

Intech Investment Management LLC raised its holdings in shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by ...

Ended 2024 with $71.1 million of cash and cash equivalents and no debtConference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8:30 ...

Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Joelle, and I will be your conference operator today.

Given this risk, we thought we'd take a look at whether Atossa Therapeutics (NASDAQ:ATOS) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the ...

The latest price target for Atossa Therapeutics (NASDAQ:ATOS) was reported by HC Wainwright & Co. on March 26, 2025. The analyst firm set a price target for $7.00 expecting ATOS to rise to within ...

Atossa Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.06. Operator: Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.